Back to MORGAN STANLEY MORGAN STANLEY

VRTXVRTX
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in VERTEX PHARMACEUTICALS INC

MORGAN STANLEY holds 3.2M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $1.6B as of 2026-Q2. The position was increased (+1.7% shares). VRTX represents 0.1% of MORGAN STANLEY's portfolio.

Current Value

$1.6B

Current Shares

3.2M

Total Value Change

+$83.1M

Total Shares Change

-16,489

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.2M
+1.7%
$1.6B0.1%$496.73
32
2026-Q1
Increased
3.2M
+2.2%
$1.4B0.1%$474.27
33
2025-Q4
Increased
3.1M
+0.4%
$1.4B0.1%$453.74
32
2025-Q3
Decreased
3.1M
-6.7%
$1.2B0.1%$395.31
0
2025-Q2
Decreased
3.3M
-2.3%
$1.5B0.1%$441.30
0
2025-Q1
Increased
3.4M
+7.5%
$1.7B0.1%$492.69
41
2024-Q4
Increased
3.2M
+4.4%
$1.3B0.1%$399.35
33
2024-Q3
Decreased
3M
-6.8%
$1.4B0.1%$462.88
0
2024-Q2
New
3.3M
-
$1.5B0.1%$468.72
53

Other major holders of VRTX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used